CERTARA USA INC

Certara USA Inc. specializes in providing advanced pharmacometric and drug development software solutions, with a core focus on modeling and simulation technologies used in regulatory science and clinical research. The company delivers licensed software platforms such as Phoenix WinNonlin and Phoenix PIRANHA, enabling federal agencies to analyze complex pharmacokinetic and pharmacodynamic data for drug approval and safety evaluation. Their technical expertise spans quantitative systems pharmacology, population modeling, noncompartmental analysis, and regulatory-compliant data visualization tools critical to FDA and NIH drug development workflows. Certara differentiates itself through deep integration of computational biology with real-world evidence and toxicology consulting, supporting end-to-end drug discovery and development pipelines under stringent government compliance standards. The contractor maintains a strong, sustained relationship with the Department of Health and Human Services, delivering software licenses and technical services to divisions including CDER, NINDS, and other NIH institutes focused on neuroscience and HEAL initiative programs. Work performed for HHS centers on supporting regulatory decision-making through data-driven pharmacometric analyses, often in support of new molecular entity submissions and post-market safety surveillance. The General Services Administration engagement reflects a long-standing federal supply schedule presence, indicating established procurement reliability and standardized service delivery. Certara operates primarily under NAICS 513210 as a software publisher, supplying specialized pharmacometric tools to government life sciences entities. Their vertical specialization lies in precision medicine, clinical trial design optimization, and toxicology modeling for regulatory submissions. The firm is positioned as a niche provider of mission-critical software and consulting services to federal agencies engaged in pharmaceutical regulation and biomedical research. Certara USA Inc. is a 2L entity headquartered in Radnor, Pennsylvania, with no federal certifications listed. Its government market positioning is defined by technical depth in pharmacometrics rather than broad IT services, serving as a trusted vendor for science-driven, compliance-sensitive applications within the U.S. health research ecosystem.